Advertisement

Topics

Shore Capital Partners and Hulin Health Announce Partnership

06:00 EDT 18 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Shore Capital Partners, a Chicago-based private equity firm focused on the healthcare industry is pleased to announce an investment in Hulin Health, LLC (“Hulin” or the “Company”). Founded in 2011, Hulin is a leading pro...

Other Sources for this Article

For Shore Capital Partners:
Ryan Kelley, 312-348-7577
rkelley@shorecp.com
or
For Hulin Health:
Clayt Hulin, 337-852-9530
clayt@hulinhealth.com
or
Media Contact:
BackBay Communications
Philip Nunes, 617-391-0792
phil.nunes@backbaycommunications.com

NEXT ARTICLE

More From BioPortfolio on "Shore Capital Partners and Hulin Health Announce Partnership"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...